Pfizer readies its next-generation COVID-19 antiviral
C&EN - 10 Mar 2025Pfizer readies its next-generation COVID-19 antiviral ...
paxlovid pfizer
Pfizer readies its next-generation COVID-19 antiviral ...
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic
Nature - 20 Mar 2025The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic ...
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat
MarketWatch - 29 Apr 2025Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat ...
Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook
WSJ - 29 Apr 2025Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook ...
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Reuters - 03 Feb 2025Smaller US winter COVID wave adds pressure to Pfizer turnaround ...
Extended Course of Paxlovid May Help Some Patients With Long COVID
Pharmacy Times - 11 Jan 2025Extended Course of Paxlovid May Help Some Patients With Long COVID ...
Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard
Fierce Pharma - 29 Oct 2024Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard ...
Paxlovid: Impact on death, hospitalization rates in older vaccinated adults weaker than thought
Newsroom | UCLA - 20 Feb 2025Paxlovid: Impact on death, hospitalization rates in older vaccinated adults weaker than thought ...
Pfizer rides Paxlovid sales growth to better-than-expected third quarter
AP News - 29 Oct 2024Pfizer rides Paxlovid sales growth to better-than-expected third quarter ...
Fig. 4 | Pfizer global supply network map. Pfizer leveraged numerous...
researchgate.net - 24 Mar 2025Fig. 4 | Pfizer global supply network map. Pfizer leveraged numerous... ...
Pfizer sees strong Q3, led by revenues for Covid vaccine, Paxlovid
Healthcare Brew - 31 Oct 2024Pfizer sees strong Q3, led by revenues for Covid vaccine, Paxlovid ...
Pfizer answers Starboard challenge with beat-and-raise quarter
BioPharma Dive - 29 Oct 2024Pfizer answers Starboard challenge with beat-and-raise quarter ...
Data suggest Paxlovid doesn't reduce severe COVID in older, vaccinated adults
CIDRAP - 21 Feb 2025Data suggest Paxlovid doesn't reduce severe COVID in older, vaccinated adults ...
Pfizer's COVID-19 portfolio outperforms as cost cuts pay off
FirstWord Pharma - 04 Feb 2025Pfizer's COVID-19 portfolio outperforms as cost cuts pay off ...
Paxlovid May Not Significantly Benefit Vaccinated Seniors, Study Says
Time Magazine - 21 Feb 2025Paxlovid May Not Significantly Benefit Vaccinated Seniors, Study Says ...
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
Fierce Pharma - 04 Feb 2025Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet ...
Pfizer CEO defends turnaround strategy as activist pressures management
Reuters - 29 Oct 2024Pfizer CEO defends turnaround strategy as activist pressures management ...
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)
ACS Publications - 25 Jul 2024Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid) ...
Pfizer, BMS and more ring in 2025 with fresh round of drug price increases: report
Fierce Pharma - 02 Jan 2025Pfizer, BMS and more ring in 2025 with fresh round of drug price increases: report ...